Epcam antibodies, activatable antibodies, and immunoconjugates, and uses thereof
TW202626091APending Publication Date: 2026-07-01IMMUNOGEN INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114132458
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-05-10
- Filing Date
- 2019-10-22
- Publication Date
- 2026-07-01
Abstract
The disclosure generally relates to antibodies and antibody fragments that specifically bind human EpCAM, EpCAM activatable antibodies, and immunoconjugates thereof, as well as, methods of making and using the antibodies, antibody fragments, activatable antibodies, and immunoconjugates, for the diagnosis and treatment of diseases such as cancer.
Need to check novelty before this filing date? Find Prior Art